• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型硼酸抑制剂的设计与探索揭示了与克拉维酸耐药巯基可变(SHV)β-内酰胺酶的重要相互作用。

Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.

机构信息

Department of Microbiology and Molecular Biology, Case Western Reserve University, Cleveland, Ohio 44106, USA.

出版信息

J Med Chem. 2013 Feb 14;56(3):1084-97. doi: 10.1021/jm301490d. Epub 2013 Feb 4.

DOI:10.1021/jm301490d
PMID:23252553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3943433/
Abstract

Inhibitor resistant (IR) class A β-lactamases pose a significant threat to many current antibiotic combinations. The K234R substitution in the SHV β-lactamase, from Klebsiella pneumoniae , results in resistance to ampicillin/clavulanate. After site-saturation mutagenesis of Lys-234 in SHV, microbiological and biochemical characterization of the resulting β-lactamases revealed that only -Arg conferred resistance to ampicillin/clavulanate. X-ray crystallography revealed two conformations of Arg-234 and Ser-130 in SHV K234R. The movement of Ser-130 is the principal cause of the observed clavulanate resistance. A panel of boronic acid inhibitors was designed and tested against SHV-1 and SHV K234R. A chiral ampicillin analogue was discovered to have a 2.4 ± 0.2 nM K(i) for SHV K234R; the chiral ampicillin analogue formed a more complex hydrogen-bonding network in SHV K234R vs SHV-1. Consideration of the spatial position of Ser-130 and Lys-234 and this hydrogen-bonding network will be important in the design of novel antibiotics targeting IR β-lactamases.

摘要

A 类β-内酰胺酶抑制剂对许多当前的抗生素组合构成了重大威胁。肺炎克雷伯氏菌的 SHV β-内酰胺酶中的 K234R 取代导致对氨苄西林/克拉维酸的耐药性。在对 SHV 中的赖氨酸 234 进行定点饱和诱变后,对产生的β-内酰胺酶进行微生物学和生物化学特性分析表明,只有 -Arg 赋予对氨苄西林/克拉维酸的耐药性。X 射线晶体学揭示了 SHV K234R 中 Arg-234 和 Ser-130 的两种构象。Ser-130 的运动是观察到克拉维酸耐药性的主要原因。设计并测试了一组硼酸抑制剂对 SHV-1 和 SHV K234R。发现一种手性氨苄西林类似物对 SHV K234R 的 K(i)值为 2.4±0.2 nM;与 SHV-1 相比,手性氨苄西林类似物在 SHV K234R 中形成了更复杂的氢键网络。考虑 Ser-130 和 Lys-234 的空间位置以及该氢键网络在手性氨苄西林类似物对 SHV K234R 的设计中非常重要。

相似文献

1
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.新型硼酸抑制剂的设计与探索揭示了与克拉维酸耐药巯基可变(SHV)β-内酰胺酶的重要相互作用。
J Med Chem. 2013 Feb 14;56(3):1084-97. doi: 10.1021/jm301490d. Epub 2013 Feb 4.
2
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition.克拉维酸对SHV-1及耐药性S130G SHV-1β-内酰胺酶的失活作用。对抑制机制的深入了解。
J Biol Chem. 2005 Oct 21;280(42):35528-36. doi: 10.1074/jbc.M501251200. Epub 2005 Jun 29.
3
Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.探究安布勒244位SHVβ-内酰胺酶变体的活性位点化学。了解抑制剂抗性的独特性质。
J Biol Chem. 2006 Sep 8;281(36):26734-44. doi: 10.1074/jbc.M603222200. Epub 2006 Jun 27.
4
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.了解SHVβ-内酰胺酶对β-内酰胺类和β-内酰胺酶抑制剂的耐药性:丝氨酸130诱变的启示
J Biol Chem. 2003 Dec 26;278(52):52724-9. doi: 10.1074/jbc.M306059200. Epub 2003 Oct 8.
5
The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV beta-lactamase: a study of ambler position Asn276.第二壳层残基在修饰SHVβ-内酰胺酶中底物和抑制剂相互作用方面的作用:对安布勒位点Asn276的研究
Biochemistry. 2009 Jun 2;48(21):4557-66. doi: 10.1021/bi9003292.
6
Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.克服对β-内酰胺酶抑制剂的耐药性:将舒巴坦与针对具有安布勒244位取代的克拉维酸耐药SHV酶的新型抑制剂进行比较。
Biochemistry. 2007 Oct 9;46(40):11361-8. doi: 10.1021/bi700792a. Epub 2007 Sep 12.
7
Avibactam and inhibitor-resistant SHV β-lactamases.阿维巴坦与耐抑制剂的SHVβ-内酰胺酶
Antimicrob Agents Chemother. 2015 Jul;59(7):3700-9. doi: 10.1128/AAC.04405-14. Epub 2015 Feb 17.
8
Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme.在一株同时产生 GES-7 酶的临床克雷伯氏肺炎菌中对抑制剂耐药的 SHVβ-内酰胺酶 SHV-107 的特性分析。
Antimicrob Agents Chemother. 2012 Feb;56(2):1042-6. doi: 10.1128/AAC.01444-10. Epub 2011 Nov 14.
9
Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.新型硼酸类过渡态抑制剂揭示 A 类 SHV-1β-内酰胺酶抑制模式的新见解。
Antimicrob Agents Chemother. 2011 Jan;55(1):174-83. doi: 10.1128/AAC.00930-10. Epub 2010 Nov 1.
10
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.KPC-2 酶中 237 位残基对底物的选择性和抑制剂识别的新作用。
Antimicrob Agents Chemother. 2010 Jul;54(7):2867-77. doi: 10.1128/AAC.00197-10. Epub 2010 Apr 26.

引用本文的文献

1
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry.通过原位点击化学发现基于硼酸的β-内酰胺酶抑制剂
Int J Mol Sci. 2025 Apr 28;26(9):4182. doi: 10.3390/ijms26094182.
2
Activity of Organoboron Compounds against Biofilm-Forming Pathogens.有机硼化合物对生物膜形成病原体的活性。
Antibiotics (Basel). 2024 Sep 29;13(10):929. doi: 10.3390/antibiotics13100929.
3
Exploring avibactam and relebactam inhibition of carbapenemase D179N variant: role of the Ω loop-held deacylation water.探索阿维巴坦和雷利巴坦对碳青霉烯酶 D179N 变体的抑制作用:ω环持有的脱酰化水的作用。
Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0035023. doi: 10.1128/aac.00350-23. Epub 2023 Sep 26.
4
Mutation of the conserved Asp-Asp pair impairs the structure, function, and inhibition of CTX-M Class A β-lactamase.保守的 Asp-Asp 对的突变会损害 CTX-M 类 A 型β-内酰胺酶的结构、功能和抑制作用。
FEBS Lett. 2021 Dec;595(24):2981-2994. doi: 10.1002/1873-3468.14215. Epub 2021 Nov 7.
5
Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant : and Approach.开发一种抗生素耐药性破解剂以重新敏感耐药菌: 和方法。
Front Cell Infect Microbiol. 2021 Aug 16;11:700198. doi: 10.3389/fcimb.2021.700198. eCollection 2021.
6
Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics.两种β-内酰胺酶变体对克拉维酸的抑制作用降低,表现出不同的毫秒动力学。
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0262820. doi: 10.1128/AAC.02628-20.
7
Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from .评估具有不同失活机制的β-内酰胺酶抑制剂对. 来源的 PenA1 碳青霉烯酶的效力
ACS Infect Dis. 2021 Apr 9;7(4):826-837. doi: 10.1021/acsinfecdis.0c00682. Epub 2021 Mar 16.
8
A Genotype-Phenotype Correlation Study of SHV β-Lactamases Offers New Insight into SHV Resistance Profiles.SHVβ-内酰胺酶的基因型-表型相关性研究为 SHV 耐药谱提供了新的见解。
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.02293-19.
9
Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.Nacubactam 增强美罗培南对产 KPC 碳青霉烯类耐药肺炎克雷伯菌的活性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00432-19. Print 2019 Aug.
10
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.超越哌拉西林他唑巴坦:头孢吡肟和 AAI101 作为一种强效的β-内酰胺-β-内酰胺酶抑制剂组合。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00105-19. Print 2019 May.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.理解碳青霉烯酶 KPC-2 中底物和抑制剂特异性的分子决定因素:探讨 Arg220 和 Glu276 的作用。
Antimicrob Agents Chemother. 2012 Aug;56(8):4428-38. doi: 10.1128/AAC.05769-11. Epub 2012 Jun 11.
3
Structural perspective of peptidoglycan biosynthesis and assembly.肽聚糖生物合成和组装的结构视角。
Annu Rev Biochem. 2012;81:451-78. doi: 10.1146/annurev-biochem-061809-112742.
4
Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme.在一株同时产生 GES-7 酶的临床克雷伯氏肺炎菌中对抑制剂耐药的 SHVβ-内酰胺酶 SHV-107 的特性分析。
Antimicrob Agents Chemother. 2012 Feb;56(2):1042-6. doi: 10.1128/AAC.01444-10. Epub 2011 Nov 14.
5
Overview of the CCP4 suite and current developments.CCP4软件包概述及当前进展
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42. doi: 10.1107/S0907444910045749. Epub 2011 Mar 18.
6
Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.探索铜绿假单胞菌头孢菌素酶中 C₃/C₄ 羧酸盐识别的序列要求:对 AmpC β-内酰胺酶可塑性的深入了解。
Protein Sci. 2011 Jun;20(6):941-58. doi: 10.1002/pro.612. Epub 2011 May 3.
7
Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as β-lactamase inhibitors.磺酰胺硼酸类化合物作为β-内酰胺酶抑制剂的设计、合成、晶体结构和抗菌活性研究。
J Med Chem. 2010 Nov 11;53(21):7852-63. doi: 10.1021/jm101015z.
8
Elucidating the role of Trp105 in the KPC-2 β-lactamase.阐明 Trp105 在 KPC-2 β-内酰胺酶中的作用。
Protein Sci. 2010 Sep;19(9):1714-27. doi: 10.1002/pro.454.
9
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.KPC-2 酶中 237 位残基对底物的选择性和抑制剂识别的新作用。
Antimicrob Agents Chemother. 2010 Jul;54(7):2867-77. doi: 10.1128/AAC.00197-10. Epub 2010 Apr 26.
10
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.对临床分离的大肠杆菌菌株产生的新型耐抑制剂β-内酰胺酶SHV-84的生化研究。
Antimicrob Agents Chemother. 2010 May;54(5):2271-2. doi: 10.1128/AAC.01442-09. Epub 2010 Mar 8.